Regulatory effect of coptisine on key genes involved in cholesterol metabolism.
- Author:
Biao CHEN
;
Dong-fang XUE
;
Bing HAN
;
Shu-ming KOU
;
Xiao-li YE
;
Xue-gang LI
- Publication Type:Journal Article
- MeSH:
Berberine;
analogs & derivatives;
pharmacology;
Cholesterol;
metabolism;
Cholesterol 7-alpha-Hydroxylase;
genetics;
metabolism;
Drugs, Chinese Herbal;
pharmacology;
Gene Expression Regulation, Enzymologic;
drug effects;
Hep G2 Cells;
Humans;
Hydroxymethylglutaryl CoA Reductases;
genetics;
metabolism;
Receptors, LDL;
genetics;
metabolism;
Triglycerides;
metabolism
- From:
China Journal of Chinese Materia Medica
2015;40(8):1548-1553
- CountryChina
- Language:Chinese
-
Abstract:
To study the effect of cholesterol and 25-OH-cholesterol on cholesterol metabolism in HepG2 cells and the effect of coptisine (Cop) extracted from Coptidis Rhizoma (CR) in reducing and regulating cholesterol. In this study, TC, TG, LDL-c and HDL-c were measured by biochemical analysis; mRNA and protein expressions of LDLR, HMGCR and CYP7A1 were detected by qRT-PCR and Western blot. According to the results, cholesterol and 25-OH-cholesterol inducing could decrease in mRNA and protein expressions of LDLR and CYP7A1, so as to increase TC and LDL-c contents. However, Cop could up-regulate mRNA and protein expressions of LDLR and CYP7A1 and down-regulate that of HMGCR, so as to reduce TC and LDL-c levels. These findings suggested that Cop has potential pharmacological activity for reducing cholesterol, and may reduce cholesterol by regulating mRNA and protein expressions of key genes involved in cholesterol metabolism, such as LDLR, CYP7A1 and HMGCR. This study laid a firm theoretical foundation for developing new natural drugs with the cholesterol-lowering activity.
